Record Details

Emilia Romagna

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Emilia Romagna
 
Creator Gasparini, Roberto
Panatto, Donatella
Dirodi, Bruna
Prato, Rosa
Amunni, Gianni
Turello, Valter
Sudano, Luigi
Cristoforoni, Paolo
Boccalini, Sara
Bonanni, Paolo
 
Subject Pharmacoeconomics; Health economics
HPV; Vaccination strategy; Screening; Emilia Romagna; Cost-effectiveness analysis
 
Description In Emilia Romagna region 84% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 29 cases of cervicocarcinoma and 14 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (13,352 €/QALY).
 
Publisher SEEd Medical Publishers
 
Contributor —
 
Date 2012-11-20
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
—
 
Format text/html
application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/455
10.7175/fe.v13i2S.455
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 13, No 2S (2012); 31-33
2240-256X
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/455/511
https://journals.edizioniseed.it/index.php/FE/article/view/455/512
 
Coverage —
—
—
 
Rights Copyright (c) 2012 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0